GILD

Featured

Could Gilead News Be Good For Biotech ETFs?

By Ian YoungJune 24, 2020

Disruptive Technology Channel

This Is NOT 2008 All Over Again

By Special To ETF TrendsMay 23, 2020

Featured

Index and Stock ETFs Rally On Vaccine Hopes From Gilead

By Ian YoungApril 29, 2020

Featured

Biotech ETFs Stable Despite Disappointing Treatment Date From Gilead

By Ian YoungApril 23, 2020

Featured

Stock Index ETFs Rally As Potential Coronavirus Treatment Surfaces

By Ian YoungApril 17, 2020

Disruptive Technology Channel

2 Biotechnology ETFs That Could Be Good For Diversification

By Ian YoungMarch 26, 2020

Equity ETF Channel

Biotech ETF Rallies on Alzheimer Treatment News

By Ian YoungOctober 22, 2019

Equity ETF Channel

Biotech Stocks Heat Up, Driving ETF Gains

By Ian YoungJune 19, 2019

Investing

Try This ETF Pair to Round Out Biotech Exposure

By David DierkingMarch 23, 2018

Equity ETFs

A Biotech Pullback Could be Afoot

By Brenton GarenOctober 26, 2017

Equity ETFs

Biotech ETFs Remain Bell of the Ball

By Brenton GarenSeptember 1, 2017

Equity ETFs

September Could be Kind to Biotechnology ETFs

By Brenton GarenAugust 29, 2017

Equity ETFs

Biotech ETFs Jump on Gilead, Kite Deal

By Max ChenAugust 28, 2017

Equity ETFs

For Biotech ETFs, It’s All About U.S. Presidential Politics

By Tom LydonSeptember 1, 2016

Equity ETFs

Pfizer Acquires Medivation, Renews Biotech M&A Bets

By Max ChenAugust 22, 2016

Equity ETFs

Reading Market Tea Leaves With a Big Biotech ETF

By Tom LydonAugust 10, 2016

Equity ETFs

Amid Biotech Rally, Investors Show Jitters

By Tom LydonAugust 4, 2016

Equity ETFs

Surprising Value in Big Biotech ETFs

By Brenton GarenJuly 21, 2016